α-Gal-Based Vaccines: Advances, Opportunities, and Perspectives - INRAE - Institut national de recherche pour l’agriculture, l’alimentation et l’environnement Accéder directement au contenu
Article Dans Une Revue (Article De Synthèse) Trends in Parasitology Année : 2020

α-Gal-Based Vaccines: Advances, Opportunities, and Perspectives

Résumé

Humans and crown catarrhines evolved with the inability to synthesize the oligosaccharide galactose-α-1,3-galactose (α-Gal). In turn, they naturally produce high quantities of the glycan-specific antibodies that can be protective against infectious agents exhibiting the same carbohydrate modification on their surface coat. The protective immunity induced by α-Gal is ensured through an antibody-mediated adaptive and cell-mediated innate immune response. Therefore, the α-Gal antigen represents an attractive and feasible target for developing glycan-based vaccines against multiple diseases. In this review article we provide an insight into our current understanding of the mechanisms involved in the protective immunity to α-Gal and discuss the possibilities and challenges in developing a single-antigen pan-vaccine for prevention and control of parasitic diseases of medical and veterinary concern.

Domaines

Vaccinologie
Fichier principal
Vignette du fichier
S1471492220302154.pdf (626.18 Ko) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-02951804 , version 1 (21-11-2022)

Licence

Paternité - Pas d'utilisation commerciale

Identifiants

Citer

Adnan Hodžić, Lourdes Mateos Hernandez, José de La Fuente, Alejandro Cabezas Cruz. α-Gal-Based Vaccines: Advances, Opportunities, and Perspectives. Trends in Parasitology, 2020, 36 (12), pp.992-1001. ⟨10.1016/j.pt.2020.08.001⟩. ⟨hal-02951804⟩
26 Consultations
32 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More